COPS7B Antibody

Code CSB-PA872526LA01HU
Size US$166
Order now
Image
  • Western Blot
    Positive WB detected in: Mouse brain tissue, Mouse stomach tissue
    All lanes: COPS7B antibody at 3µg/ml
    Secondary
    Goat polyclonal to rabbit IgG at 1/50000 dilution
    Predicted band size: 30, 19, 31 kDa
    Observed band size: 30 kDa

  • Immunohistochemistry of paraffin-embedded human testis tissue using CSB-PA872526LA01HU at dilution of 1:100

  • Immunofluorescent analysis of Hela cells using CSB-PA872526LA01HU at dilution of 1:100 and Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG(H+L)

The Latest Promotion Free Antibody trial simple
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Full Product Name
Rabbit anti-Homo sapiens (Human) COPS7B Polyclonal antibody
Uniprot No.
Target Names
COPS7B
Alternative Names
COP9 Complex Homolog Subunit 7b antibody; COP9 Constitutive Photomorphogenic Homolog Subunit 7b antibody; COP9 Signalasome Subunit 7b antibody; COP9 signalosome complex subunit 7b antibody; COPS7B antibody; CSN7B_HUMAN antibody; JAB1 Containing Signalosome Subunit 7b antibody; JAB1-containing signalosome subunit 7b antibody; SGN7b antibody; Signalosome subunit 7b antibody
Raised in
Rabbit
Species Reactivity
Human, Mouse
Immunogen
Recombinant Human COP9 signalosome complex subunit 7b protein (1-157AA)
Immunogen Species
Homo sapiens (Human)
Conjugate
Non-conjugated

The COPS7B Antibody (Product code: CSB-PA872526LA01HU) is Non-conjugated. For COPS7B Antibody with conjugates, please check the following table.

Available Conjugates
Conjugate Product Code Product Name Application
HRP CSB-PA872526LB01HU COPS7B Antibody, HRP conjugated ELISA
FITC CSB-PA872526LC01HU COPS7B Antibody, FITC conjugated
Biotin CSB-PA872526LD01HU COPS7B Antibody, Biotin conjugated ELISA
Clonality
Polyclonal
Isotype
IgG
Purification Method
>95%, Protein G purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
Form
Liquid
Tested Applications
ELISA, WB, IHC, IF
Recommended Dilution
Application Recommended Dilution
WB 1:2000-1:5000
IHC 1:20-1:200
IF 1:50-1:200
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Component of the COP9 signalosome complex (CSN), a complex involved in various cellular and developmental processes. The CSN complex is an essential regulator of the ubiquitin (Ubl) conjugation pathway by mediating the deneddylation of the cullin subunits of SCF-type E3 ligase complexes, leading to decrease the Ubl ligase activity of SCF-type complexes such as SCF, CSA or DDB2. The complex is also involved in phosphorylation of p53/TP53, JUN, I-kappa-B-alpha/NFKBIA, ITPK1 and IRF8/ICSBP, possibly via its association with CK2 and PKD kinases. CSN-dependent phosphorylation of TP53 and JUN promotes and protects degradation by the Ubl system, respectively.
Subcellular Location
Cytoplasm. Nucleus.
Protein Families
CSN7/EIF3M family, CSN7 subfamily
Database Links

HGNC: 16760

OMIM: 616010

KEGG: hsa:64708

STRING: 9606.ENSP00000272995

UniGene: Hs.335061

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*